25 September 2026 – Sino Biopharmaceutical Limited (trading as SBP Group) has released its 2026 Interim Report in both English and Chinese on the company’s website (www.sbpgroup.com) and on HKEXnews (www.hkexnews.hk). Registered shareholders who have previously chosen hard-copy delivery will receive printed reports enclosed with the company’s latest corporate-communication package.

Key operational details:

• Digital first: SBP Group “strongly recommends” shareholders access the web-based version of the Interim Report and all future corporate documents to reduce paper consumption and expedite information flow.

• Switching to print: Shareholders unable to view the online version can request printed copies of the current and all future corporate communications free of charge by completing and returning the enclosed reply form to Tricor Investor Services Limited, the company’s Hong Kong branch share registrar, or by emailing is-ecom@vistra.com.

• Email registration: Providing a valid email address enables electronic receipt of publication notices and actionable corporate documents. Until a functioning address is supplied, shareholders will continue to receive hard-copy notices by post.

• Administrative support: Enquiries may be directed to Tricor’s hotline on (852) 2980 1333, Monday to Friday, 9:00 a.m.–6:00 p.m. (excluding public holidays).

The notice, signed by Company Secretary Ms Lai Kuen and dated 24 September 2026, reiterates that corporate communications encompass annual and interim reports, meeting notices, circulars, listing documents, proxy forms, and any materials requiring shareholder action.